Agilent Technologies, Inc. $A Shares Acquired by Troy Asset Management Ltd

Troy Asset Management Ltd grew its position in Agilent Technologies, Inc. (NYSE:AFree Report) by 0.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,404,161 shares of the medical research company’s stock after buying an additional 6,341 shares during the period. Agilent Technologies accounts for approximately 7.8% of Troy Asset Management Ltd’s investment portfolio, making the stock its 4th largest position. Troy Asset Management Ltd owned 0.85% of Agilent Technologies worth $308,574,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the business. Norges Bank acquired a new position in shares of Agilent Technologies in the 2nd quarter worth approximately $395,088,000. AQR Capital Management LLC raised its position in Agilent Technologies by 424.1% in the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after purchasing an additional 1,652,244 shares during the period. Ameriprise Financial Inc. lifted its stake in Agilent Technologies by 132.2% during the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after purchasing an additional 1,340,161 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its position in shares of Agilent Technologies by 10.7% during the second quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock worth $1,560,964,000 after buying an additional 1,273,994 shares during the period. Finally, Ilex Capital Partners UK LLP purchased a new position in shares of Agilent Technologies during the second quarter worth $96,684,000. 87.41% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on A shares. Morgan Stanley assumed coverage on Agilent Technologies in a report on Tuesday, December 2nd. They issued an “overweight” rating for the company. Robert W. Baird raised their price target on Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a report on Tuesday, November 25th. Wells Fargo & Company boosted their price objective on shares of Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Citigroup lifted their target price on shares of Agilent Technologies from $165.00 to $185.00 and gave the stock a “buy” rating in a research note on Tuesday, November 25th. Finally, HSBC started coverage on Agilent Technologies in a report on Tuesday, January 20th. They issued a “buy” rating and a $180.00 target price on the stock. Two research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $164.50.

Get Our Latest Stock Analysis on Agilent Technologies

Agilent Technologies Trading Up 0.7%

Agilent Technologies stock opened at $125.80 on Friday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $160.27. The firm has a market cap of $35.58 billion, a price-to-earnings ratio of 27.53, a price-to-earnings-growth ratio of 3.65 and a beta of 1.30. The firm’s 50 day moving average price is $137.84 and its two-hundred day moving average price is $135.41.

Agilent Technologies (NYSE:AGet Free Report) last issued its earnings results on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, topping the consensus estimate of $1.58 by $0.01. The business had revenue of $1.86 billion during the quarter, compared to analysts’ expectations of $1.83 billion. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.Agilent Technologies’s revenue was up 9.4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, research analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be paid a dividend of $0.255 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio (DPR) is 22.32%.

Insider Buying and Selling at Agilent Technologies

In other news, VP Rodney Gonsalves sold 3,000 shares of the firm’s stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total transaction of $464,970.00. Following the transaction, the vice president owned 31,846 shares in the company, valued at approximately $4,935,811.54. This trade represents a 8.61% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Padraig Mcdonnell sold 911 shares of the company’s stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $143.24, for a total value of $130,491.64. Following the sale, the chief executive officer owned 32,058 shares of the company’s stock, valued at approximately $4,591,987.92. This trade represents a 2.76% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.26% of the company’s stock.

About Agilent Technologies

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Featured Stories

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.